Ignite Creation Date:
2025-12-24 @ 1:20 PM
Ignite Modification Date:
2026-07-08 @ 6:18 PM
Study NCT ID:
NCT04104295
Status:
WITHDRAWN
Last Update Posted:
2021-04-20
First Post:
2019-09-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Use of Ultrasound in Nasogastric Tube Placement in Children Admitted to the Pediatric ICU
Sponsor:
Yale University
Organization:
Study Overview
Official Title:
The Use of Ultrasound to Determine Correct Nasogastric Tube Placement in Children Admitted to the Pediatric ICU: a Pilot Study
Status:
WITHDRAWN
Status Verified Date:
2021-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Study never began.
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if ultrasound (US), when used by the clinician, can determine the presence of nasogastric tube (NGT) in the stomach of patients admitted to the pediatric intensive care unit (PICU).
Detailed Description:
Currently, the standard of care is to routinely obtain an X-ray (XR) after every nasogastric tube (NGT) placement in the pediatric intensive care unit (PICU). After obtaining informed consent and the child's assent, a short (less than 10 minutes) ultrasound (US) scan of the abdomen within 2 hours of the routine XR.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: